2021 ISHEN guidelines on animal models of hepatic encephalopathy
dc.contributor.author | DeMorrow, Sharon | |
dc.contributor.author | Cudalbu, Cristina | |
dc.contributor.author | Davies, Nathan A. | |
dc.contributor.author | Jayakumar, Arumugam R. | |
dc.contributor.author | Rose, Christopher | |
dc.date.accessioned | 2021-06-28T12:40:08Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2021-06-28T12:40:08Z | |
dc.date.issued | 2021-04-01 | |
dc.identifier.uri | http://hdl.handle.net/1866/25305 | |
dc.publisher | Wiley | fr |
dc.subject | Acute liver failure | fr |
dc.subject | Behaviour | fr |
dc.subject | Bile duct ligation | fr |
dc.subject | Chronic liver disease | fr |
dc.subject | Hepatic encephalopathy | fr |
dc.subject | Hyperammonemia | fr |
dc.subject | Liver toxins | fr |
dc.subject | Neurological deficits | fr |
dc.subject | Portocaval anastomosis | fr |
dc.title | 2021 ISHEN guidelines on animal models of hepatic encephalopathy | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de médecine | fr |
dc.identifier.doi | 10.1111/liv.14911 | |
dcterms.abstract | This working group of the International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) was commissioned to summarize and update current efforts in the development and characterization of animal models of hepatic encephalopathy (HE). As defined in humans, HE in animal models is based on the underlying degree and severity of liver pathology. Although hyperammonemia remains the key focus in the pathogenesis of HE, other factors associated with HE have been identified, together with recommended animal models, to help explore the pathogenesis and pathophysiological mechanisms of HE. While numerous methods to induce liver failure and disease exist, less have been characterized with neurological and neurobehavioural impairments. Moreover, there still remains a paucity of adequate animal models of Type C HE induced by alcohol, viruses and non-alcoholic fatty liver disease; the most common etiologies of chronic liver disease. | fr |
dcterms.isPartOf | urn:ISSN:1478-3223 | fr |
dcterms.isPartOf | urn:ISSN:1478-3231 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | 10.1111/liv.14911 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Liver international | fr |
oaire.citationVolume | 41 | fr |
oaire.citationIssue | 7 | fr |
oaire.citationStartPage | 1474 | fr |
oaire.citationEndPage | 1488 | fr |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.